Janssen Pharmaceutica
Belgium
1 December 2019 - 30 November 2020
Principal institution: Johnson & Johnson
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Janssen Pharmaceutica published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 9 | 1.23 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 5 | 0.30 | |
| Nature Communications | 3 | 0.23 | |
| Nature Immunology | 1 | 0.02 | |
| Nature Medicine | 1 | 0.06 | |
| Chemistry | 4 | 0.93 | |
Top articles by Altmetric score in current window
Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities
Nature Immunology
2020-03-16
Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis
Nature Communications
2020-01-28
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
Nature Communications
2020-04-03
Hydrogen Bonding Phase-Transfer Catalysis with Ionic Reactants: Enantioselective Synthesis of γ-Fluoroamines
Journal of the American Chemical Society
2020-08-05
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
